- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02296385
Genotype-related Effects of PUFA
November 17, 2014 updated by: Nestlé
Response to PUFA Intervention According to PPAR Genotypes
To assess the bioefficacy of omega-3 fatty acids (provided by intake of fish oil supplements) depending on genotype of relevant factors in lipid metabolism
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
To assess the bioefficacy of omega-3 fatty acids (provided by intake of fish oil supplements) depending on genotype of relevant factors in lipid metabolism.
Study Type
Interventional
Enrollment (Actual)
200
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 38 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy adult between 18 and 40 years of age
- BMI between 18.5 and 30 kg/m2
- Sedentary to moderate physical activity habits
Exclusion Criteria:
- Concomitant treatment: Consumption of dietary supplements or any medication that can affect the study outcomes
- Actively smoking
- Suspected abuse of alcohol or illicit drugs
- Significant illness within the two weeks prior to study start or any active systemic infection or medical condition that may require treatment during the study
- Known or suspected medical condition related to coagulation
- Subject who cannot be expected to comply with the study procedures
- Currently participating or having participated in another clinical trial during the last 4 weeks prior to beginning of this study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Supplementation
|
Triple Strength Fish Oil
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes in triglyceride levels in plasma
Time Frame: Baseline and 6 weeks intervention
|
Baseline and 6 weeks intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assess bioefficacy of EPA and DHA supplementation
Time Frame: Baseline and 6 weeks intervention
|
The bioefficacy will be evaluated by characterizing and measuring the effects on lipid metabolism, glucose metabolism and insulin resistance, and inflammatory response
|
Baseline and 6 weeks intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Maria Elizabeth Tejero Barrera, PhD, Instituto Nacional de Medicina Genómica
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2012
Primary Completion (Actual)
May 1, 2014
Study Completion (Actual)
August 1, 2014
Study Registration Dates
First Submitted
November 12, 2014
First Submitted That Met QC Criteria
November 17, 2014
First Posted (Estimate)
November 20, 2014
Study Record Updates
Last Update Posted (Estimate)
November 20, 2014
Last Update Submitted That Met QC Criteria
November 17, 2014
Last Verified
November 1, 2014
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 11.16.NRC
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Triple Strength Fish Oil
-
Sulaiman AlRajhi CollegesUnknown
-
Hospital Infantil de Mexico Federico GomezCentro Universitario del Sur, Guadalajara; Instituto de Servicios Descentralizados...CompletedInsulin Resistance | Child Obesity | Metabolic ComplicationMexico
-
Sheffield Hallam UniversitySheffield Teaching Hospitals NHS Foundation Trust; Rotherham Doncaster and...CompletedTraumatic Brain InjuryUnited Kingdom
-
University of CopenhagenAnjo A/SCompletedObesity | Cardiovascular Disease | Metabolic Syndrome | Growth | Blood Pressure
-
DSM Nutritional Products, Inc.Completed
-
National Science Council, TaiwanCompletedMajor Depressive DisorderTaiwan
-
Rigshospitalet, DenmarkDanish Child Cancer FoundationRecruitingLeukemia, Acute LymphoblasticDenmark
-
Tufts UniversityPrevention PharmaceuticalsTerminated
-
Liverpool John Moores UniversityCompleted
-
Stanford UniversityNordic NaturalsCompleted